Sedana Medical AB Share Price
Equities
SEDANA
SE0015988373
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.15 SEK | -2.21% | +54.68% | -4.36% |
04-25 | Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-25 | Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 188M 17.29M 1.38B | Sales 2025 * | 239M 22.07M 1.76B | Capitalization | 2.2B 203M 16.16B |
---|---|---|---|---|---|
Net income 2024 * | -53M -4.88M -389M | Net income 2025 * | -42M -3.87M -308M | EV / Sales 2024 * | 10.5 x |
Net cash position 2024 * | 223M 20.55M 1.64B | Net cash position 2025 * | 94.2M 8.68M 692M | EV / Sales 2025 * | 8.79 x |
P/E ratio 2024 * |
-42.1
x | P/E ratio 2025 * |
-50.7
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.5% |
Latest transcript on Sedana Medical AB
1 day | -2.21% | ||
1 week | +54.68% | ||
Current month | +38.35% | ||
1 month | +41.99% | ||
3 months | +4.68% | ||
6 months | +9.22% | ||
Current year | -4.36% |
Managers | Title | Age | Since |
---|---|---|---|
Johannes Doll
CEO | Chief Executive Officer | 43 | 30/09/21 |
Johan Spetz
DFI | Director of Finance/CFO | - | 03/04/22 |
Peter Fröberg
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/10/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hilde Furberg
BRD | Director/Board Member | 65 | 31/12/21 |
Director/Board Member | 49 | 18/05/20 | |
Claus Bjerre
CHM | Chairman | 53 | 09/05/21 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 22.15 | -2.21% | 323,833 |
30/04/24 | 22.65 | +7.35% | 188,696 |
29/04/24 | 21.1 | +2.18% | 249,392 |
26/04/24 | 20.65 | +9.14% | 502,248 |
25/04/24 | 18.92 | +29.95% | 1,243,460 |
Delayed Quote Nasdaq Stockholm, May 02, 2024 at 04:29 pm
More quotesEPS Revisions
- Stock Market
- Equities
- SEDANA Stock